Anti-AMPA receptor encephalitis: The family of glutamatergic autoencephalitides further expands

Neurology

Volumn 84, Issue 24, 2015, Pages 2390-2391

  Panzer, Jessica A ^a,b   Dale, Russell C ^c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; AUTOANTIBODY; CYCLOPHOSPHAMIDE; RITUXIMAB;

AUTOIMMUNITY; CLINICAL FEATURE; ENCEPHALITIS; HUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; BLOOD; CEREBROSPINAL FLUID; FEMALE; IMMUNOLOGY; MALE;

AUTOANTIBODIES; ENCEPHALITIS; FEMALE; HUMANS; MALE; RECEPTORS, AMPA;

EID: 84931054029     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001693     Document Type: Review

References (13)

1. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009;65:424-434.
2. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013;12:157-165.
3. Höftberger R, van Sonderen A, Leypoldt F, et al. Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology 2015;84:2403-2412.
4. Gleichman AJ, Panzer J, Baumann BH, Dalmau J, Lynch DR. Antigenic and mechanistic characterization of anti-AMPA receptor encephalitis. Ann Clin Transl Neurol 2014;1:180-189.
5. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010;30:5866-5875.
6. Peng X, Hughes EG, Moscato EH, et al. Cellular plasticity induced by anti-a-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor encephalitis antibodies. Ann Neurol 2015;77:381-398.
7. Dale RC, Brilot F, Duffy LV, et al. Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease. Neurology 2014;83:142-150.
8. Leypoldt F, Armangue T, Dalmau J. Autoimmune ence-phalopathies. Ann NY Acad Sci 2015;1338:94-114.
9. Prüss H, Finke C, Höltje M, et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 2012;72:902-911.
10. Armangue T, Leypoldt F, Málaga I, et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 2014;75:317-323.
11. Adang LA, Lynch DR, Panzer JA. Pediatric anti-NMDA receptor encephalitis is seasonal. Ann Clin Transl Neurol 2014;1:921-925.
12. Bien CG, Vincent A, Barnett MH, et al. Immunopathol-ogy of autoantibody-associated encephalitides: clues for pathogenesis. Brain 2012;135:1622-1638.
13. Irani SR, Gelfand JM, Bettcher BM, et al. Effect of ritux-imab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy. JAMA Neurol 2014;71:896-900.